Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6638838 | 0.79 | TYR (0.34) | CHRNA7 | |
| SCHEMBL2237394 | 0.75 | ALDH1A1 (0.39) | — | |
| SCHEMBL2904251 | 0.74 | TYR (0.43) | CHRNA7 | |
| SCHEMBL20621292 | 0.74 | CHRNA7 (0.33) | CHRNA7 | |
| SCHEMBL12371005 | 0.74 | HDAC8 (0.37) | CHRNA7 | |
| SCHEMBL9756951 | 0.73 | KDM4E (0.51) | — | |
| SCHEMBL9756953 | 0.73 | KDM4E (0.51) | — | |
| SCHEMBL23015843 | 0.72 | CCNC (0.36) | CHRNA7 | |
| SCHEMBL16167426 | 0.71 | HDAC4 (0.42) | — | |
| SCHEMBL16167432 | 0.71 | HDAC4 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220162210-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2022-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162210-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | OR10J3, CTCF, LAGE3 | CHRNA7 1791/4885PIM1 1880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.